FDA Approved: MOUNJARO — Original Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved MOUNJARO (tirzepatide) from Eli Lilly under Original Application NDA 215866 for adults with type 2 diabetes mellitus to improve glycemic control.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MOUNJARO (tirzepatide)

Snippet

ORIG AP for MOUNJARO (TIRZEPATIDE)